Valuation — not yet established
No valuation for Medxoom is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($13.8M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Medxoom
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Buyout/LBO (Add-on)† | — | ▮ | ▮ |
| Oct 2022 | Seed Round | $2.4M | ▮ | ▮ |
| Mar 2021 | Early Stage VC | $8.1M | ▮ | ▮ |
| May 2019 | Seed Round | $3.3M | ▮ | ▮ |
How Medxoom's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Medxoom, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Medxoom raised?
- Medxoom has raised $13.8M in total funding across 4 recorded rounds.
- When did Medxoom last raise?
- Medxoom last raised in Jun 2025 (Buyout/LBO (Add-on)†).